Teva Pharmaceutical Industries Ltd share price logo

Teva Pharmaceutical Industries Ltd Share Price

NYSE: TEVA

Large Cap

$31.20

+0.84

(+2.78%)

as on

Teva Pharmaceutical Industries Ltd Stock Performance

as on December 23, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $30.5
    $31.28
    downward going graph

    2.24%

    Downside

    0.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.47
    $31.28
    downward going graph

    60.05%

    Downside

    0.26%

    Upside

    downward going graph

Teva Pharmaceutical Industries Ltd share price movements today

Previous Close
$30.35
Open
$30.67
Volume
7.8M
Day's Low - High
$30.5 - $31.28
52 Week Low - High
$12.47 - $31.28

Teva Pharmaceutical Industries Ltd Historical Returns

1 Month Return
+ 28.91 %
3 Month Return
+ 60.46 %
1 Year Return
+ 40.52 %
3 Year Return
+ 237.77 %
5 Year Return
+ 219.45 %

Teva Pharmaceutical Industries Ltd Stock Fundamentals & Key Indicators

Check Teva Pharmaceutical Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$34.8B

EPS (TTM)

2.6374

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

49.7

Industry PE ratio

17.123164556962024

PEG Ratio

1.2934

EBITDA

-

Revenue (TTM)

-

Profit Margin

4.25%

Return On Equity TTM

9.71%

Teva Pharmaceutical Industries Ltd Stock Valuation

Track how Teva Pharmaceutical Industries Ltd P/E has moved over time to understand its valuation trends.

Teva Pharmaceutical Industries Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.34x)

March 31, 2022

Industry (17.12x)

December 23, 2025

Today (49.70x)

December 23, 2025

Highest (12.90x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 49.70x

Teva Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Teva Pharmaceutical Industries Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$34.8B219.45%49.74.25%
BUY$23.2BNA19.6140.65%
BUY$44.1BNA2213.81%
BUY$14.5B50.65%34.6115.95%
BUY$54.2B-22.56%20.5828.21%

Stock Returns calculator for Teva Pharmaceutical Industries Ltd Stock including INR - Dollar returns

The Teva Pharmaceutical Industries Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Teva Pharmaceutical Industries Ltd investment value today

Current value as on today

₹1,45,899

Returns

₹45,899

(+45.9%)

Returns from Teva Pharmaceutical Industries Ltd Stock

₹40,477 (+40.48%)

Dollar Returns*

₹5,422 (+5.42%)

Analyst Recommendation on Teva Pharmaceutical Industries Ltd Stock

Based on 9 analysts

SELL

0.00%

Buy

33.33%

Hold

66.67%

Sell

Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Teva Pharmaceutical Industries Ltd. Average target price of $31.86

Teva Pharmaceutical Industries Ltd Share Price Target

Get share price movements and forecasts by analysts on Teva Pharmaceutical Industries Ltd.

What analysts predicted

2.07%UPSIDE

Target Price

$31.86

Current Price

$31.2

Analyzed by

9 Analysts

Target

$31.86

Teva Pharmaceutical Industries Ltd target price $31.86, a slight upside of 2.07% compared to current price of $31.2. According to 9 analysts rating.

Teva Pharmaceutical Industries Ltd Stock’s Investor Sentiment and Interest

Search interest for Teva Pharmaceutical Industries Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Teva Pharmaceutical Industries Ltd Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
3,878
3,850
4,457
3,819
4,164
4,331
4,229
3,891
4,176
4,480
Gross Profit
1,796
1,851
2,416
1,771
2,024
2,148
2,120
1,877
2,102
2,304
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-872
69
463
-139
-846
-437
-217
214
282
433
Net Profit Margin
-22.49%
1.79%
10.39%
-3.64%
-20.32%
-10.09%
-5.13%
5.50%
6.75%
9.67%

Teva Pharmaceutical Industries Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
19,652
21,903
22,385
18,854
16,887
16,659
15,878
14,925
15,846
16,544
Gross Profit
11,356
11,859
10,825
8,296
7,536
7,726
7,594
6,973
7,645
8,063
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
1,588
329
-16,265
-2,150
-999
-3,990
417
-2,446
-559
-1,639
Net Profit Margin
8.08%
1.50%
-72.66%
-11.40%
-5.92%
-23.95%
2.63%
-16.39%
-3.53%
-9.91%

Global Institutional Holdings in Teva Pharmaceutical Industries Ltd

Funds
Holdings
FMR Inc
5.07%
BlackRock Inc
4.74%
MENORA MIVTACHIM HOLDINGS LIMITED
3.36%
Ion Asset Management Ltd.
3.34%
Phoenix Financial Ltd
3.29%

Teva Pharmaceutical Industries Ltd News & Key Events

  • img

    Today's Timeline - 19 December

    Fri, 02:10 PM

    -

    Teva and Alvotech secure U.S. settlement date for AVT06, a proposed biosimilar to Eylea, pending FDA approval.

    Fri, 08:31 PM

    -

    Teva's Chief Accounting Officer sells 12,300 shares for $371K amid a 1.15% drop in stock price.

Insights on Teva Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Teva Pharmaceutical Industries Ltd has shown positive revenue growth over the last three quarters. Their revenue has increased from $3.89 billion to $4.48 billion, with an average increase of 6.8% each quarter.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Teva Pharmaceutical Industries Ltd has shown a positive trend in its net profit over the last 6 quarters, increasing from a loss of $846.0 million to a profit of $433.0 million. This marks an average increase of 91.1% in net profit each quarter, indicating strong improvement in financial performance.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TEVA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, TEVA stock has moved up by 28.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 41.3% return, outperforming this stock by 0.8%

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
OrganisationTeva Pharmaceutical Industries Ltd
Headquarters124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020
IndustryHealth Technology
CEOMr. Richard D. Francis
E-voting on sharesClick here to vote

Key Management of Teva Pharmaceutical Industries Ltd

Name

Title

Mr. Matthew Shields

Executive Vice President of Global Operations

Mr. Amir Weiss

Senior VP & Chief Accounting Officer

Mr. Christopher J. Stevo CFA

Senior Vice President of Investor Relations & Competitive Intelligence

Mr. David R. Mcavoy J.D.

Executive VP & Chief Legal Officer

Mr. Richard D. Francis

President, CEO & Director

Dr. Eric A. Hughes M.D., Ph.D.

Executive VP of Global R&D and Chief Medical Officer

Ms. Christine Fox

Executive VP of U.S. Commercial Business

Kathleen Veit

Senior Vice President, Global Compliance & Ethics Officer

Mr. Eliyahu Sharon Kalif

Executive VP & CFO

Mr. Richard Gordon Daniell

Executive Vice President of European Commercial

FAQs

What is Teva Pharmaceutical Industries Ltd share price today?

Teva Pharmaceutical Industries Ltd share price today is $31.2 as on at the close of the market. Teva Pharmaceutical Industries Ltd share today touched a day high of $31.28 and a low of $30.5.

What is the 52 week high and 52 week low for Teva Pharmaceutical Industries Ltd share?

Teva Pharmaceutical Industries Ltd share touched a 52 week high of $31.28 on and a 52 week low of $12.47 on . Teva Pharmaceutical Industries Ltd stock price today i.e. is closed at $31.2,which is 0.26% down from its 52 week high and 150.30% up from its 52 week low.

What is Teva Pharmaceutical Industries Ltd's market capitalisation today?

Teva Pharmaceutical Industries Ltd market capitalisation is $0.03T as on .

How to invest in Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Teva Pharmaceutical Industries Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Teva Pharmaceutical Industries Ltd Shares that will get you 0.0481 shares as per Teva Pharmaceutical Industries Ltd share price of $31.2 per share as on December 23, 2025 at 2:29 am IST.

What is the minimum amount required to buy Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?

Indian investors can start investing in Teva Pharmaceutical Industries Ltd (TEVA) shares with as little as ₹89.714 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.14 in Teva Pharmaceutical Industries Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Teva Pharmaceutical Industries Ltd share’s latest price of $31.2 as on December 23, 2025 at 2:29 am IST, you will get 0.3205 shares of Teva Pharmaceutical Industries Ltd. Learn more about fractional shares .

What are the returns that Teva Pharmaceutical Industries Ltd has given to Indian investors in the last 5 years?

Teva Pharmaceutical Industries Ltd stock has given 219.45% share price returns and 21.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?